Lenvatinib shows positive results vs sorafenib in unresectable hepatocellular carcinoma

AI-based blood test outperforms ultrasound in early liver cancer detection

Helio Genomics, an AI-driven healthcare company specializing in diagnostics technology and test development for cancer detection, has released results from its latest clinical trial demonstrating the superior performance of their HelioLiver Dx test compared to ultrasound.

June 14, 2024

Vol.50 No.24

Clinical Roundup

Liver surgery to remove cancer can now be a safe outpatient procedure

Robotic liver surgery can be a safe outpatient procedure, according to a study published in the Journal of the American College of Surgeons. In fact, 8% of the patients sampled in the analysis were discharged to go home on the same day.

June 14, 2024

Vol.50 No.24

In Brief

Mauricio Garcia named Jerome S. Levy, MD, Chair in Gastroenterology and Hepatology at UAMS

The University of Arkansas for Medical Sciences College of Medicine invested Mauricio S. Garcia in the Jerome S. Levy, MD, Chair in Gastroenterology and Hepatology during a May 1 ceremony.

May 10, 2024

Vol.50 No.19

Clinical Roundup

Imfinzi regimen reduces the risk of disease progression or death in liver cancer eligible for embolization

Positive results from the EMERALD-1 phase III trial showed AstraZeneca’s Imfinzi (durvalumab) in combination with transarterial chemoembolization, or TACE, and bevacizumab demonstrated a statistically significant and clinically meaningful improvement in the primary endpoint of progression-free survival compared to TACE alone in patients with hepatocellular carcinoma eligible for embolization.

March 29, 2024

Vol.50 No.13

Clinical Roundup

UC Davis study: TB vaccine shrinks liver cancer tumors in mice

A UC Davis Health study found that a single dose of Bacillus Calmette-Guérin, or BCG, the vaccine for tuberculosis, reduced liver tumor burden and extended the survival of mice with liver cancer. The study, published in Advanced Science, is the first to show the promising effects of the vaccine in treating liver cancer.

March 08, 2024

Vol.50 No.10

Clinical Roundup

Cedars-Sinai study finds two key proteins could help protect the liver from cancerous cells

Cedars-Sinai investigators have discovered how the liver defends itself against cancer. Their study, published in the peer-reviewed Journal of Hepatology, suggests targets for therapies to protect the liver both from cancers that originate there and cancers that spread to the liver from other parts of the body.

December 15, 2023

Vol.49 No.46

Lenvatinib shows positive results vs sorafenib in unresectable hepatocellular carcinoma

YOU MAY BE INTERESTED IN

AI-based blood test outperforms ultrasound in early liver cancer detection

Liver surgery to remove cancer can now be a safe outpatient procedure

Mauricio Garcia named Jerome S. Levy, MD, Chair in Gastroenterology and Hepatology at UAMS

Imfinzi regimen reduces the risk of disease progression or death in liver cancer eligible for embolization

UC Davis study: TB vaccine shrinks liver cancer tumors in mice

Cedars-Sinai study finds two key proteins could help protect the liver from cancerous cells

Renew today!

Subscriber content

Login